Related Experiment Video
Updated: Jun 2, 2025
08:00
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
7.5K
A Prognostic Survival Model Based on Endocrine-Related Gene Expression in Acute Myelogenous Leukemia
Weiran Lv1, Yun Wang2, Fang Hu1
1Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Acta Haematologica
|January 14, 2025
Summary
A new model using endocrine-related gene expression improves survival prediction for acute myelogenous leukemia (AML) patients. This endocrine signature aids in stratifying AML prognosis and enhancing patient outcome predictions.
Area of Science:
- Oncology
- Genomics
- Biostatistics
Background:
- Accurate survival prediction in acute myelogenous leukemia (AML) remains a clinical challenge.
- Existing prognostic models require enhancement for precise patient stratification.
Purpose of the Study:
- To develop a predictive survival model for AML using endocrine-related gene expression.
- To identify an endocrine signature for improved AML prognosis stratification.
Main Methods:
- Utilized RNA sequencing data and clinical information from public AML datasets (GEO, TCGA, TARGET).
- Constructed a risk model incorporating seven endocrine-related genes.
- Validated the model's predictive efficacy and prognostic significance.
Main Results:
- The developed endocrine-related risk model accurately predicted 5-year survival rates in training and validation cohorts.
- The endocrine signature demonstrated independent prognostic value in AML patients.
- A nomogram combining endocrine risk score with classical factors significantly improved prediction accuracy.
Conclusions:
- The endocrine-related prognostic model enhances the accuracy of survival prediction in acute myelogenous leukemia.
- This signature offers a novel approach for stratifying AML patient prognosis.
